Gang Hu

Design and biological evaluation of novel 4-(2-fluorophenoxy)quinoline derivatives bearing an imidazolone moiety as c-Met kinase inhibitors.

P. Gong, Zhuang Guo, W. Liao, 2015, Bioorganic & medicinal chemistry.

Palladium-catalyzed three-component reaction for the synthesis of 3,3-disubstituted allylic alcohols with regio- and stereoselectivity

P. Gong, Gang Hu, Yajing Liu, 2018 .

Design, synthesis and biological evaluation of novel benzothiazole derivatives bearing semicarbazone moiety as antitumor agents

P. Gong, Gang Hu, Junjie Ma, 2015, Chemical Research in Chinese Universities.

Design, synthesis and biological evaluation of novel 4-arylaminopyrimidine derivatives possessing a hydrazone moiety as dual inhibitors of L1196M ALK and ROS1.

X. Zhai, Daiying Zuo, P. Gong, 2016, European journal of medicinal chemistry.

Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine derivatives as potent antitumor agents

P. Gong, Yanfang Zhao, Gang Hu, 2019, New Journal of Chemistry.

Design, Synthesis, and Biological Evaluation of 4‐Phenoxyquinoline Derivatives Containing Benzo[d]thiazole‐2‐yl Urea as c‐Met Kinase Inhibitors

P. Gong, Zijian Liu, Yu Wang, 2016, Archiv der Pharmazie.

Design and optimization of novel 4-(2-fluorophenoxy)quinoline derivatives bearing a hydrazone moiety as c-Met kinase inhibitors.

X. Ji, Tiemin Sun, P. Gong, 2014, European journal of medicinal chemistry.

Discovery of novel 2,4-diarylaminopyrimidine analogues as ALK and ROS1 dual inhibitors to overcome crizotinib-resistant mutants including G1202R.

X. Zhai, Yucheng Gu, Daiying Zuo, 2018, European journal of medicinal chemistry.